NL8203034A - Thiazolidinylalkyleenpiperidine-derivaten. - Google Patents

Thiazolidinylalkyleenpiperidine-derivaten. Download PDF

Info

Publication number
NL8203034A
NL8203034A NL8203034A NL8203034A NL8203034A NL 8203034 A NL8203034 A NL 8203034A NL 8203034 A NL8203034 A NL 8203034A NL 8203034 A NL8203034 A NL 8203034A NL 8203034 A NL8203034 A NL 8203034A
Authority
NL
Netherlands
Prior art keywords
thiazolidinedione
pharmaceutically acceptable
piperazinyl
acid addition
addition salt
Prior art date
Application number
NL8203034A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8203034A publication Critical patent/NL8203034A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NL8203034A 1981-08-03 1982-07-29 Thiazolidinylalkyleenpiperidine-derivaten. NL8203034A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28935281 1981-08-03
US06/289,352 US4367335A (en) 1981-08-03 1981-08-03 Thiazolidinylalkylene piperazine derivatives

Publications (1)

Publication Number Publication Date
NL8203034A true NL8203034A (nl) 1983-03-01

Family

ID=23111164

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8203034A NL8203034A (nl) 1981-08-03 1982-07-29 Thiazolidinylalkyleenpiperidine-derivaten.

Country Status (28)

Country Link
US (1) US4367335A (ru)
JP (2) JPS5826877A (ru)
KR (1) KR880001478B1 (ru)
AT (1) AT381705B (ru)
AU (1) AU560655B2 (ru)
BE (1) BE894022A (ru)
CA (1) CA1172636A (ru)
CH (1) CH652398A5 (ru)
DE (1) DE3228990A1 (ru)
DK (1) DK162991C (ru)
ES (1) ES514264A0 (ru)
FI (1) FI76793C (ru)
FR (1) FR2510572B1 (ru)
GB (1) GB2106104B (ru)
GR (1) GR76172B (ru)
HU (1) HU191187B (ru)
IE (1) IE53641B1 (ru)
IL (1) IL66434A0 (ru)
IT (1) IT1149329B (ru)
LU (1) LU84316A1 (ru)
NL (1) NL8203034A (ru)
NZ (1) NZ201159A (ru)
OA (1) OA07172A (ru)
PH (1) PH18220A (ru)
PT (1) PT75366B (ru)
SE (1) SE452320B (ru)
YU (1) YU44074B (ru)
ZA (1) ZA825479B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456756A (en) * 1981-08-03 1984-06-26 Mead Johnson & Company Spirothiazolidinyl piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4620006A (en) * 1982-08-11 1986-10-28 Eastman Kodak Company Acid salts of 1-(cyanoalkyl)-4-guanylpiperazines
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
CA1278792C (en) * 1985-05-06 1991-01-08 Joseph P. Yevich Antipsychotic fused-ring pyridinylpiperazine derivatives
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4675403A (en) * 1985-10-16 1987-06-23 American Home Products Corporation 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US5801186A (en) 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US5116970A (en) * 1988-02-18 1992-05-26 New James S Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
JPH0415948U (ru) * 1990-05-31 1992-02-10
US5194436A (en) * 1991-01-10 1993-03-16 Hoechst-Roussel Pharmaceuticals Inc. 1-piperazinyl-2-butenes and -2-butynes
US5130315A (en) * 1991-01-10 1992-07-14 Raymond R. Wittekind 1-piperazinyl-2-butenes and -2-butynes
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
WO2003093236A1 (en) * 2002-05-02 2003-11-13 Euro-Celtique, S.A. 1-(pyrid-2-yl)-piperazine compounds as metabotropic glutamate receptor inhibitor
WO2006013445A2 (en) * 2004-07-28 2006-02-09 Ranbaxy Laboratories Limited Thiazolidinedione derivatives as alpha adrenergic receptor antagonists

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2672460A (en) * 1952-06-24 1954-03-16 American Cyanamid Co Disubstituted piperazines and methods of preparing the same
US2748125A (en) * 1954-04-26 1956-05-29 American Cyanamid Co 1-substituted-4-sulfamylpiperazine and method of preparing the same
NL265085A (ru) * 1960-05-24
FR1435004A (fr) * 1965-02-04 1966-04-15 Sobio Lab Dérivés de thiazolidine-dione-2, 4- et procédé de préparation
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
DE1695410A1 (de) * 1967-04-20 1971-04-08 Merck Patent Gmbh Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen
US3635976A (en) * 1967-12-20 1972-01-18 Pennwalt Corp 1 - heterocyclic alkyl-1 2 3 4-tetrahydroquinazolinones and analgesic intermediates thereof
US3822266A (en) * 1968-12-24 1974-07-02 Hoffmann La Roche (3-(1-piperazinyl)-2-hydroxy-propoxy)acetanilides
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4017622A (en) * 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives
DE2263211A1 (de) * 1972-12-23 1974-07-04 Boehringer Sohn Ingelheim Neue arylpiperazine und verfahren zu ihrer herstellung
US3919230A (en) * 1974-02-07 1975-11-11 Smithkline Corp {62 -Naphthylmethyl piperazinyl derivatives
FR2285883A1 (fr) * 1974-09-30 1976-04-23 Cerm Cent Europ Rech Mauvernay Nouveaux composes chimiques a activite bronchospasmolytique et antitussive, et procede pour leur obtention
US3940398A (en) * 1975-01-23 1976-02-24 E. R. Squibb & Sons, Inc. 2-[[4-(Azine or diazine or triazine)-1-piperazinyl]alkyl]-1H-benz[de]isoquinoline-1,3(2H)-diones
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4060615A (en) * 1976-02-18 1977-11-29 Mead Johnson & Company 2-Piperazinyl-6,7-dimethoxyquinazolines
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
GB1518559A (en) * 1976-04-12 1978-07-19 Science Union & Cie Naphthyl derivatives processes for their preparation an pharmaceutical compositions containing them
US4078063A (en) * 1976-09-24 1978-03-07 Merck & Co., Inc. Piperazinylpyridines
US4101548A (en) * 1977-02-22 1978-07-18 Bristol-Myers Company 1,2,3-Thiadiazole amides
HU173380B (hu) * 1977-02-25 1979-04-28 Richter Gedeon Vegyeszet Sposob poluchenija novogo proizvodnogo piridil-piperazina i kislo-additivnykh solejj
DE2727469A1 (de) * 1977-06-18 1978-12-21 Hoechst Ag Neue hexahydropyrimidine, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
US4138561A (en) * 1977-09-30 1979-02-06 Bristol-Myers Company Cyanocarboxamidines and quinazoline process
DE2862059D1 (en) * 1977-12-29 1982-11-11 Synthelabo Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications
FR2418798A1 (fr) * 1978-03-03 1979-09-28 Science Union & Cie Nouvelles piperazines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
FI791926A (fi) * 1978-06-20 1979-12-21 Synthelabo Fenylpiperazinderivat
US4161595A (en) * 1978-10-02 1979-07-17 Bristol-Myers Company Levulinic acid salt

Also Published As

Publication number Publication date
AU560655B2 (en) 1987-04-16
ATA299482A (de) 1986-04-15
YU158682A (en) 1985-04-30
DK343682A (da) 1983-02-04
IE53641B1 (en) 1989-01-04
FI822667L (fi) 1983-02-04
JPS5826877A (ja) 1983-02-17
GB2106104A (en) 1983-04-07
HU191187B (en) 1987-01-28
GB2106104B (en) 1985-05-09
ES8307800A1 (es) 1983-08-01
JPH02270821A (ja) 1990-11-05
KR840001167A (ko) 1984-03-28
FI822667A0 (fi) 1982-07-30
CH652398A5 (de) 1985-11-15
IT1149329B (it) 1986-12-03
ES514264A0 (es) 1983-08-01
JPH0371410B2 (ru) 1991-11-13
IL66434A0 (en) 1982-12-31
DK162991C (da) 1992-06-01
FI76793B (fi) 1988-08-31
SE452320B (sv) 1987-11-23
BE894022A (fr) 1983-02-03
DE3228990A1 (de) 1983-03-03
PH18220A (en) 1985-04-30
LU84316A1 (fr) 1983-06-07
JPH0235754B2 (ru) 1990-08-13
OA07172A (fr) 1984-04-30
DK162991B (da) 1992-01-06
US4367335A (en) 1983-01-04
IE821852L (en) 1983-02-03
PT75366A (en) 1982-09-01
SE8204550D0 (sv) 1982-08-02
GR76172B (ru) 1984-08-03
PT75366B (en) 1985-11-20
NZ201159A (en) 1985-10-11
SE8204550L (sv) 1983-02-04
IT8248909A0 (it) 1982-07-29
AT381705B (de) 1986-11-25
ZA825479B (en) 1983-04-27
CA1172636A (en) 1984-08-14
YU44074B (en) 1990-02-28
FR2510572A1 (fr) 1983-02-04
FI76793C (fi) 1988-12-12
AU8566382A (en) 1983-02-10
KR880001478B1 (ko) 1988-08-13
FR2510572B1 (fr) 1986-05-09

Similar Documents

Publication Publication Date Title
NL8203034A (nl) Thiazolidinylalkyleenpiperidine-derivaten.
US4411901A (en) Benzisothiazole and benzisoxazole piperazine derivatives
NL193283C (nl) 4,4-Dialkyl-1-[4-[4-(2-pirimidinyl)-1-piperazinyl]-butyl]-2,6- piperazinedionen.
US4452799A (en) Benzisothiazole and benzisoxazole piperazine derivatives
JPS6084282A (ja) １−ヘテロアリ−ル−４−〔（２．５−ピロリジンジオン−１−イル）アルキル〕ピペラジン誘導体
NL8204974A (nl) 2-4-(4,4-dialkyl-2,6-piperidinedion-1-yl)butyl-1-piperazinylpyridines; een werkwijze voor het bereiden daarvan; hun toepassing in farmaceutische preparaten.
US4456756A (en) Spirothiazolidinyl piperazine derivatives
US6291467B1 (en) Heteroaromatic derivatives
US3829572A (en) Analgesic composition
JPH0546341B2 (ru)

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BC A request for examination has been filed
BV The patent application has lapsed